title: Lucinactant approved for respiratory distress syndrome.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D004338:Drug Combinations; D005233:Fatty Alcohols / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D010715:Phosphatidylglycerols / Q000009:adverse effects / Q000627:therapeutic use*; D011506:Proteins / Q000009:adverse effects / Q000627:therapeutic use*; D011663:Pulmonary Surfactants / Q000009:adverse effects / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*
chemical_list: D004338:Drug Combinations; D005233:Fatty Alcohols; D010715:Phosphatidylglycerols; D011506:Proteins; D011663:Pulmonary Surfactants; C502722:lucinactant